How Are Natural-Based Polymers Shaping the Future of Cancer Immunotherapy—A Review

References

• Xiao, Y.; Yu, D. Tumor Microenvironment as a Therapeutic Target in Cancer. Pharmacol. Ther. 2021, 221, 107753. DOI: 10.1016/j.pharmthera.2020.107753.
   PubMed Web of Science ®Google Scholar
• Tiwari, A.; Trivedi, R.; Lin, S.-Y. Tumor Microenvironment: Barrier or Opportunity towards Effective Cancer Therapy. J. Biomed. Sci. 2022, 29, 83. DOI: 10.1186/s12929-022-00866-3.
   PubMed Web of Science ®Google Scholar
• Dzobo, K.; Senthebane, D. A.; Dandara, C. The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited. Cancers 2023, 15, 376. DOI: 10.3390/cancers15020376.
   PubMed Web of Science ®Google Scholar
• Wherry, E. J. T Cell Exhaustion. Nat. Immunol. 2011, 12, 492–499. DOI: 10.1038/ni.2035.
   PubMed Web of Science ®Google Scholar
• DeVito, N. C.; Plebanek, M. P.; Theivanthiran, B.; Hanks, B. A. Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion. Front. Immunol. 2019, 10, 2876. DOI: 10.3389/fimmu.2019.02876.
   PubMed Web of Science ®Google Scholar
• Leach, D. R.; Krummel, M. F.; Allison, J. P. Enhancement of Antitumor Immunity by CTLA-4 Blockade. Science 1996, 271, 1734–1736. DOI: 10.1126/science.271.5256.1734.
   PubMed Web of Science ®Google Scholar
• Reddy, M. S.; Ponnamma, D.; Choudhary, R.; Sadasivuni, K. K. A Comparative Review of Natural and Synthetic Biopolymer Composite Scaffolds. Polymers 2021, 13, 1105. DOI: 10.3390/polym13071105.
   PubMed Web of Science ®Google Scholar
• Deng, G.; Wong, W.-T.; Huang, M.; Wu, R.; Lai, W.-F. Chapter 8 – Self-Healing Properties of Hydrogels Based on Natural Polymers. In Hydrogels Based on Natural Polymers; Chen, Y. B. T.-H. B. on N. P., Ed.; Elsevier: Netherlands, 2020; pp 223–245. DOI: 10.1016/B978-0-12-816421-1.00008-2.
   Google Scholar
• Razavi, S. M. R.; Oh, J.; Sett, S.; Feng, L.; Yan, X.; Hoque, M. J.; Liu, A.; Haasch, R. T.; Masoomi, M.; Bagheri, R.; et al. Superhydrophobic Surfaces Made from Naturally Derived Hydrophobic Materials. ACS Sustain. Chem. Eng. 2017, 5, 11362–11370. DOI: 10.1021/acssuschemeng.7b02424.
   Web of Science ®Google Scholar
• Ghalia, M. A.; Abdelrasoul, A.; 7 – Compressive and Fracture Toughness of Natural and Synthetic Fiber-Reinforced Polymer. In Fibre-Reinforced Composites and Hybrid Composites, Woodhead Publishing Series in Composites Science and Engineering; Jawaid, M., Thariq, M., Saba, N. B. T.-M. and P. T. of B., Eds.; Woodhead Publishing: United Kingdom, 2019; pp 123–140. DOI: 10.1016/B978-0-08-102292-4.00007-2.
   Google Scholar
• Esfahani, K.; Roudaia, L.; Buhlaiga, N.; Del Rincon, S.; V; Papneja, N.; Miller, W. H. A. Review of Cancer Immunotherapy: From the Past, to the Present, to the Future. Curr. Oncol. 2020, 27, 87–97. DOI: 10.3747/co.27.5223.
   PubMed Web of Science ®Google Scholar
• Kimiz-Gebologlu, I.; Gulce-Iz, S.; Biray-Avci, C. Monoclonal Antibodies in Cancer Immunotherapy. Mol. Biol. Rep. 2018, 45, 2935–2940. DOI: 10.1007/s11033-018-4427-x.
   PubMed Web of Science ®Google Scholar
• Berraondo, P.; Sanmamed, M. F.; Ochoa, M. C.; Etxeberria, I.; Aznar, M. A.; Pérez-Gracia, J. L.; Rodríguez-Ruiz, M. E.; Ponz-Sarvise, M.; Castañón, E.; Melero, I. Cytokines in Clinical Cancer Immunotherapy. Br. J. Cancer 2019, 120, 6–15. DOI: 10.1038/s41416-018-0328-y.
   PubMed Web of Science ®Google Scholar
• Guermonprez, P.; Valladeau, J.; Zitvogel, L.; Théry, C.; Amigorena, S. Antigen Presentation and T Cell Stimulation by Dendritic Cells. Annu. Rev. Immunol. 2002, 20, 621–667. DOI: 10.1146/annurev.immunol.20.100301.064828.
   PubMed Web of Science ®Google Scholar
• Restifo, N. P.; Dudley, M. E.; Rosenberg, S. A. Adoptive Immunotherapy for Cancer: Harnessing the T Cell Response. Nat. Rev. Immunol. 2012, 12, 269–281. DOI: 10.1038/nri3191.
   PubMed Web of Science ®Google Scholar
• Brenner, M. K.; Heslop, H. E. Adoptive T Cell Therapy of Cancer. Curr. Opin. Immunol. 2010, 22, 251–257. DOI: 10.1016/J.COI.2010.01.020.
   PubMed Web of Science ®Google Scholar
• Geethakumari, P. R.; Ramasamy, D. P.; Dholaria, B.; Berdeja, J.; Kansagra, A. Balancing Quality, Cost, and Access During Delivery of Newer Cellular and Immunotherapy Treatments. Curr. Hematol. Malig. Rep. 2021, 16, 345–356. DOI: 10.1007/s11899-021-00635-3.
   PubMed Web of Science ®Google Scholar
• Gomes-Silva, D.; Ramos, C. A. Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line. Biotechnol. J. 2018, 13, 1700097. DOI: 10.1002/biot.201700097.
   Web of Science ®Google Scholar
• Sprent, J.; Surh, C. D. Normal T Cell Homeostasis: The Conversion of Naive Cells into Memory-Phenotype Cells. Nat. Immunol. 2011, 12, 478–484. DOI: 10.1038/ni.2018.
   PubMed Web of Science ®Google Scholar
• Zhang, N.; Bevan, M. J. CD8+ T Cells: Foot Soldiers of the Immune System. Immunity 2011, 35, 161–168. DOI: 10.1016/j.immuni.2011.07.010.
   PubMed Web of Science ®Google Scholar
• Takada, K.; Jameson, S. C. Naive T Cell Homeostasis: From Awareness of Space to a Sense of Place. Nat. Rev. Immunol. 2009, 9, 823–832. DOI: 10.1038/nri2657.
   PubMed Web of Science ®Google Scholar
• Ma, A.; Koka, R.; Burkett, P. Diverse Functions OF Il-2, Il-15, and Il-7 IN Lymphoid Homeostasis. Annu. Rev. Immunol. 2006, 24, 657–679. DOI: 10.1146/annurev.immunol.24.021605.090727.
   PubMed Web of Science ®Google Scholar
• Malek, T. R. The Biology of Interleukin-2. Annu. Rev. Immunol. 2008, 26, 453–479. DOI: 10.1146/annurev.immunol.26.021607.090357.
   PubMed Web of Science ®Google Scholar
• Spolski, R.; Leonard, W. J. Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity. Annu. Rev. Immunol. 2008, 26, 57–79. DOI: 10.1146/annurev.immunol.26.021607.090316.
   PubMed Web of Science ®Google Scholar
• Mescher, M. F.; Curtsinger, J. M.; Agarwal, P.; Casey, K. A.; Gerner, M.; Hammerbeck, C. D.; Popescu, F.; Xiao, Z. Signals Required for Programming Effector and Memory Development by CD8+ T Cells. Immunol. Rev. 2006, 211, 81–92. DOI: 10.1111/j.0105-2896.2006.00382.x.
   PubMed Web of Science ®Google Scholar
• Arakaki, R.; Yamada, A.; Kudo, Y.; Hayashi, Y.; Ishimaru, N. Mechanism of Activation-Induced Cell Death of T Cells and Regulation of FasL Expression. Crit. Rev. Immunol. 2014, 34, 301–314. DOI: 10.1615/critrevimmunol.2014009988.
   PubMed Web of Science ®Google Scholar
• Green, D. R.; Droin, N.; Pinkoski, M. Activation-Induced Cell Death in T Cells. Immunol. Rev. 2003, 193, 70–81. DOI: 10.1034/j.1600-065X.2003.00051.x.
   PubMed Web of Science ®Google Scholar
• Klein, E.; Ben-Bassat, H.; Neumann, H.; Ralph, P.; Zeuthen, J.; Polliack, A.; Vánky, F. Properties of the K562 Cell Line, Derived from a Patient with Chronic Myeloid Leukemia. Int. J. Cancer 1976, 18, 421–431. DOI: 10.1002/ijc.2910180405.
   PubMed Web of Science ®Google Scholar
• Butler, M. O.; Lee, J.-S.; Ansen, S.; Neuberg, D.; Hodi, F. S.; Murray, A. P.; Drury, L.; Berezovskaya, A.; Mulligan, R. C.; Nadler, L. M.; et al. Long-Lived Antitumor CD8+ Lymphocytes for Adoptive Therapy Generated Using an Artificial Antigen-Presenting Cell. Clin. Cancer Res. 2007, 13, 1857–1867. DOI: 10.1158/1078-0432.CCR-06-1905.
   PubMed Web of Science ®Google Scholar
• Paczesny, S.; Banchereau, J.; Wittkowski, K. M.; Saracino, G.; Fay, J.; Palucka, A. K. Expansion of Melanoma-Specific Cytolytic CD8+ T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34+ Progenitor-Derived Dendritic Cells. J. Exp. Med. 2004, 199, 1503–1511. DOI: 10.1084/jem.20032118.
   PubMed Web of Science ®Google Scholar
• Almand, B.; Resser, J. R.; Lindman, B.; Nadaf, S.; Clark, J. I.; Kwon, E. D.; Carbone, D. P.; Gabrilovich, D. I. Clinical Significance of Defective Dendritic Cell Differentiation in Cancer. Clin. Cancer Res. 2000, 6, 1755–1766.
   PubMed Web of Science ®Google Scholar
• Gross, G.; Eshhar, Z. Endowing T Cells with Antibody Specificity Using Chimeric T Cell Receptors. FASEB J. 1992, 6, 3370–3378. DOI: 10.1096/fasebj.6.15.1464371.
   PubMed Web of Science ®Google Scholar
• D’Aloia, M. M.; Zizzari, I. G.; Sacchetti, B.; Pierelli, L.; Alimandi, M. CAR-T Cells: The Long and Winding Road to Solid Tumors. Cell Death Dis. 2018, 9, 282. DOI: 10.1038/s41419-018-0278-6.
   PubMed Web of Science ®Google Scholar
• Moon, J. J.; Huang, B.; Irvine, D. J. Engineering Nano- and Microparticles to Tune Immunity. Adv. Mater. 2012, 24, 3724–3746. DOI: 10.1002/adma.201200446.
   PubMed Web of Science ®Google Scholar
• Schmid, D.; Park, C. G.; Hartl, C. A.; Subedi, N.; Cartwright, A. N.; Puerto, R. B.; Zheng, Y.; Maiarana, J.; Freeman, G. J.; Wucherpfennig, K. W.; et al. T Cell-Targeting Nanoparticles Focus Delivery of Immunotherapy to Improve Antitumor Immunity. Nat. Commun. 2017, 8, 1747. DOI: 10.1038/s41467-017-01830-8.
   PubMed Web of Science ®Google Scholar
• Steenblock, E. R.; Fahmy, T. M. A Comprehensive Platform for Ex Vivo T-Cell Expansion Based on Biodegradable Polymeric Artificial Antigen-Presenting Cells. Mol. Ther. 2008, 16, 765–772. DOI: 10.1038/mt.2008.11.
   PubMed Web of Science ®Google Scholar
• Begines, B.; Ortiz, T.; Pérez-Aranda, M.; Martínez, G.; Merinero, M.; Argüelles-Arias, F.; Alcudia, A. Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects. Nanomaterials 2020, 10, 1403. DOI: 10.3390/nano10071403.
   Web of Science ®Google Scholar
• Perica, K.; De León Medero, A.; Durai, M.; Chiu, Y. L.; Bieler, J. G.; Sibener, L.; Niemöller, M.; Assenmacher, M.; Richter, A.; Edidin, M.; et al. Nanoscale Artificial Antigen Presenting Cells for T Cell Immunotherapy. Nanomedicine 2014, 10, 119–129. DOI: 10.1016/j.nano.2013.06.015.
   PubMed Web of Science ®Google Scholar
• Meyer, R. A.; Sunshine, J. C.; Perica, K.; Kosmides, A. K.; Aje, K.; Schneck, J. P.; Green, J. J. Biodegradable Nanoellipsoidal Artificial Antigen Presenting Cells for Antigen Specific T-Cell Activation. Small 2015, 11, 1519–1525. DOI: 10.1002/smll.201402369.
   PubMed Web of Science ®Google Scholar
• Kumar, S.; Anselmo, A. C.; Banerjee, A.; Zakrewsky, M.; Mitragotri, S. Shape and Size-Dependent Immune Response to Antigen-Carrying Nanoparticles. J. Control Release 2015, 220, 141–148. DOI: 10.1016/J.JCONREL.2015.09.069.
   PubMed Web of Science ®Google Scholar
• Sunshine, J. C.; Perica, K.; Schneck, J. P.; Green, J. J. Particle Shape Dependence of CD8+ T Cell Activation by Artificial Antigen Presenting Cells. Biomaterials 2014, 35, 269–277. DOI: 10.1016/J.BIOMATERIALS.2013.09.050.
   PubMed Web of Science ®Google Scholar
• Glenny, A. T.; Pope, C. G.; Waddington, H.; Wallace, U. Immunological Notes. XVII–XXIV. J. Pathol. 1926, 29, 31–40. DOI: 10.1002/path.1700290106.
   Google Scholar
• Sokolovska, A.; Hem, S. L.; HogenEsch, H. Activation of Dendritic Cells and Induction of CD4+ T Cell Differentiation by Aluminum-Containing Adjuvants. Vaccine 2007, 25, 4575–4585. DOI: 10.1016/j.vaccine.2007.03.045.
   PubMed Web of Science ®Google Scholar
• Desbien, A. L.; Reed, S. J.; Bailor, H. R.; Cauwelaert, N. D.; Laurance, J. D.; Orr, M. T.; Fox, C. B.; Carter, D.; Reed, S. G.; Duthie, M. S. Squalene Emulsion Potentiates the Adjuvant Activity of the TLR4 Agonist, GLA, via Inflammatory Caspases, IL‐18, and IFN‐γ. Eur. J. Immunol. 2015, 45, 407–417. DOI: 10.1002/eji.201444543.
   PubMed Web of Science ®Google Scholar
• Ismaili, J.; Rennesson, J.; Aksoy, E.; Vekemans, J.; Vincart, B.; Amraoui, Z.; Van Laethem, F.; Goldman, M.; Dubois, P. M. Monophosphoryl Lipid A Activates Both Human Dendritic Cells and T Cells. J. Immunol. 2002, 168, 926–932. DOI: 10.4049/jimmunol.168.2.926.
   PubMed Web of Science ®Google Scholar
• Chu, R. S.; Targoni, O. S.; Krieg, A. M.; Lehmann, P. V.; Harding, C. V. CpG Oligodeoxynucleotides Act as Adjuvants That Switch on T Helper 1 (Th1) Immunity. J. Exp. Med. 1997, 186, 1623–1631. DOI: 10.1084/jem.186.10.1623.
   PubMed Web of Science ®Google Scholar
• Hanahan, D.; Weinberg, R. A. Hallmarks of Cancer: The Next Generation. Cell 2011, 144, 646–674. DOI: 10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Dunn, G. P.; Bruce, A. T.; Ikeda, H.; Old, L. J.; Schreiber, R. D. Cancer Immunoediting: From Immunosurveillance to Tumor Escape. Nat. Immunol. 2002, 3, 991–998. DOI: 10.1038/ni1102-991.
   PubMed Web of Science ®Google Scholar
• Curran, M. A.; Montalvo, W.; Yagita, H.; Allison, J. P. PD-1 and CTLA-4 Combination Blockade Expands Infiltrating T Cells and Reduces Regulatory T and Myeloid Cells within B16 Melanoma Tumors. Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 4275–4280. DOI: 10.1073/pnas.0915174107.
   PubMed Web of Science ®Google Scholar
• Rajabi, M.; Mousa, S. A. The Role of Angiogenesis in Cancer Treatment. Biomedicines 2017, 5, 34. DOI: 10.3390/biomedicines5020034.
   PubMed Web of Science ®Google Scholar
• Ferrara, N. Vascular Endothelial Growth Factor as a Target for Anticancer Therapy. Oncologist 2004, 9 Suppl 1, 2–10. DOI: 10.1634/theoncologist.9-suppl_1-2.
   PubMed Web of Science ®Google Scholar
• Pugh, C. W.; Ratcliffe, P. J. Regulation of Angiogenesis by Hypoxia: Role of the HIF System. Nat. Med. 2003, 9, 677–684. DOI: 10.1038/nm0603-677.
   PubMed Web of Science ®Google Scholar
• Diaz-Gonzalez, J. A.; Russell, J.; Rouzaut, A.; Gil-Bazo, I.; Montuenga, L. Targeting Hypoxia and Angiogenesis through HIF-1alpha Inhibition. Cancer Biol. Ther. 2005, 4, 1055–1062. DOI: 10.4161/cbt.4.10.2195.
   PubMed Web of Science ®Google Scholar
• Zhong, H.; Chiles, K.; Feldser, D.; Laughner, E.; Hanrahan, C.; Georgescu, M.-M.; Simons, J. W.; Semenza, G. L. Modulation of Hypoxia-Inducible Factor 1α Expression by the Epidermal Growth Factor/Phosphatidylinositol 3-Kinase/PTEN/AKT/FRAP Pathway in Human Prostate Cancer Cells: Implications for Tumor Angiogenesis and Therapeutics. Cancer Res. 2000, 60, 1541–1545.
   PubMed Web of Science ®Google Scholar
• Ferrara, N.; Hillan, K. J.; Novotny, W. Bevacizumab (Avastin), a Humanized Anti-VEGF Monoclonal Antibody for Cancer Therapy. Biochem. Biophys. Res. Commun. 2005, 333, 328–335. DOI: 10.1016/j.bbrc.2005.05.132.
   PubMed Web of Science ®Google Scholar
• Ebewele, R. O. Polymer Science and Technology; CRC Press: Boca Raton, FL, 2000. DOI: 10.1016/0261-3069(95)90127-2.
   Google Scholar
• Kamatar, A.; Gunay, G.; Acar, H. Natural and Synthetic Biomaterials for Engineering Multicellular Tumor Spheroids. Polymers 2020, 12, 2506. DOI: 10.3390/polym12112506.
   PubMed Web of Science ®Google Scholar
• Negut, I.; Dorcioman, G.; Grumezescu, V. Scaffolds for Wound Healing Applications. Polymers 2020, 12, 2010. DOI: 10.3390/polym12092010.
   PubMed Web of Science ®Google Scholar
• Fan, D.; Staufer, U.; Accardo, A. Engineered 3D Polymer and Hydrogel Microenvironments for Cell Culture Applications. Bioengineering 2019, 6, 113. DOI: 10.3390/bioengineering6040113.
   PubMedGoogle Scholar
• Abbasian, M.; Massoumi, B.; Mohammad-Rezaei, R.; Samadian, H.; Jaymand, M. Scaffolding Polymeric Biomaterials: Are Naturally Occurring Biological Macromolecules More Appropriate for Tissue Engineering? Int. J. Biol. Macromol. 2019, 134, 673–694. DOI: 10.1016/j.ijbiomac.2019.04.197.
   PubMed Web of Science ®Google Scholar
• Koide, S. S. Chitin-Chitosan: Properties, Benefits and Risks. Nutr. Res. 1998, 18, 1091–1101. DOI: 10.1016/S0271-5317(98)00091-8.
   Web of Science ®Google Scholar
• Kafetzopoulos, D.; Martinou, A.; Bouriotis, V. Bioconversion of Chitin to Chitosan: Purification and Characterization of Chitin Deacetylase from Mucor rouxii. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 2564–2568. DOI: 10.1073/pnas.90.7.2564.
   PubMed Web of Science ®Google Scholar
• Hirano, S.; Zhang, M.; Chung, B. G.; Kim, S. K. The N-Acylation of Chitosan Fibre and the N-Deacetylation of Chitin Fibre and Chitin–Cellulose Blended Fibre at a Solid State. Carbohydr. Polym. 2000, 41, 175–179. DOI: 10.1016/S0144-8617(99)00081-8.
   Web of Science ®Google Scholar
• Colvin, J. R. The Biosynthesis of Cellulose. In Carbohydrates: Structure and Function; Elsevier: Netherlands, 1980; pp 543–570.
   Google Scholar
• Cannon, R. E.; Anderson, S. M. Biogenesis of Bacterial Cellulose. Crit. Rev. Microbiol. 1991, 17, 435–447. DOI: 10.3109/10408419109115207.
   PubMed Web of Science ®Google Scholar
• Marchessault, R. H.; Sundararajan, P. R. 2 – Cellulose. In The Polysaccharides, Aspinall, G. O. B. T.-T. P., Ed.; Academic Press: Cambridge, MA, 1983; pp 11–95. DOI: 10.1016/B978-0-12-065602-8.50007-8.
   Google Scholar
• Fujino, T.; Itoh, T. Architecture of the Cell Wall of a Green Alga, Oocystis apiculata. Protoplasma 1994, 180, 39–48. DOI: 10.1007/BF01379222.
   Web of Science ®Google Scholar
• Smidsrød, O.; Skja, G. Alginate as Immobilization Matrix for Cells. Trends Biotechnol. 1990, 8, 71–78.
   PubMed Web of Science ®Google Scholar
• Haug, A.; Larsen, B.; Smidsrød, O.; Smidsrød, O.; Eriksson, G.; Blinc, R.; Paušak, S.; Ehrenberg, L.; Dumanović, J. Studies on the Sequence of Uronic Acid Residues in Alginic Acid. Acta Chem. Scand. 1967, 21, 691–704. DOI: 10.3891/acta.chem.scand.21-0691.
   Google Scholar
• Gombotz, W. R.; Wee, S. Protein Release from Alginate Matrices. Adv. Drug Deliv. Rev. 1998, 31, 267–285. DOI: 10.1016/s0169-409x(97)00124-5.
   PubMed Web of Science ®Google Scholar
• Rowley, J. A.; Madlambayan, G.; Mooney, D. J. Alginate Hydrogels as Synthetic Extracellular Matrix Materials. Biomaterials 1999, 20, 45–53. DOI: 10.1016/s0142-9612(98)00107-0.
   PubMed Web of Science ®Google Scholar
• Fraser, J. R. E.; Laurent, T. C.; Laurent, U. B. G. Hyaluronan: Its Nature, Distribution, Functions and Turnover. J. Intern. Med. 1997, 242, 27–33. DOI: 10.1046/j.1365-2796.1997.00170.x.
   PubMed Web of Science ®Google Scholar
• Price, R. D.; Berry, M. G.; Navsaria, H. A. Hyaluronic Acid: The Scientific and Clinical Evidence. J. Plast. Reconstr. Aesthet. Surg. 2007, 60, 1110–1119. DOI: 10.1016/j.bjps.2007.03.005.
   PubMed Web of Science ®Google Scholar
• Ambrosio, L.; Borzacchiello, A.; Netti, P. A.; Nicolais, L. Rheological Study on Hyaluronic Acid and Its Derivative Solutions. J. Macromol. Sci. Pure Appl. Chem. 1999, 36, 991–1000. DOI: 10.1081/MA-100101578.
   Web of Science ®Google Scholar
• Laurent, T. C.; Fraser, J. R. E. The Properties and Turnover of Hyaluronan. In Ciba Found Symp; Wiley Online Library: Hoboken, NJ, 1986; Vol. 124, pp 9–29.
   Google Scholar
• Chen, W. Y. J. Functions of Hyaluronan in Wound Repair. In Hyaluronan; Elsevier: Netherlands, 2002; pp 147–156.
   Google Scholar
• Rayahin, J. E.; Buhrman, J. S.; Zhang, Y.; Koh, T. J.; Gemeinhart, R. A. High and Low Molecular Weight Hyaluronic Acid Differentially Influence Macrophage Activation. ACS Biomater. Sci. Eng. 2015, 1, 481–493. DOI: 10.1021/acsbiomaterials.5b00181.
   PubMed Web of Science ®Google Scholar
• Vigetti, D.; Karousou, E.; Viola, M.; Deleonibus, S.; De Luca, G.; Passi, A. Hyaluronan: Biosynthesis and Signaling. Biochim. Biophys. Acta 2014, 1840, 2452–2459. DOI: 10.1016/j.bbagen.2014.02.001.
   PubMed Web of Science ®Google Scholar
• Misra, S.; Hascall, V. C.; Markwald, R. R.; Ghatak, S. Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer. Front. Immunol. 2015, 6, 201. DOI: 10.3389/fimmu.2015.00201.
   PubMed Web of Science ®Google Scholar
• Senbanjo, L. T.; Chellaiah, M. A. CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells. Front. Cell Dev. Biol. 2017, 5, 18. DOI: 10.3389/fcell.2017.00018.
   PubMed Web of Science ®Google Scholar
• Kuo, J. W.; Prestwich, G. D. Materials of Biological Origin-Materials Analysis and Implant Uses, Comprehensive Biomaterials. In Comprehensive Biomaterials, Ducheyne, P., Ed.; Elsevier: Netherlands, 2010.
   Google Scholar
• Valle, D.; Romeo, F. A. Cross-Linked Esters of Hyaluronic Acid. Google Patents, September 18, 1990.
   Google Scholar
• O'Neill, M. A.; Selvendran, R. R.; Morris, V. J. Structure of the Acidic Extracellular Gelling Polysaccharide Produced by Pseudomonas elodea. Carbohydr. Res. 1983, 124, 123–133. DOI: 10.1016/0008-6215(83)88360-8.
   Web of Science ®Google Scholar
• Chandrasekaran, R.; Millane, R. P.; Arnott, S.; Atkins, E. D. T. The Crystal Structure of Gellan. Carbohydr. Res. 1988, 175, 1–15. DOI: 10.1016/0008-6215(88)80151-4.
   Web of Science ®Google Scholar
• Milas, M.; Shi, X.; Rinaudo, M. On the Physicochemical Properties of Gellan Gum. Biopolymers 1990, 30, 451–464. DOI: 10.1002/bip.360300322.
   PubMed Web of Science ®Google Scholar
• Chauhan, A. S.; Jain, N. K.; Diwan, P. V.; Khopade, A. J. Solubility Enhancement of Indomethacin with Poly (Amidoamine) Dendrimers and Targeting to Inflammatory Regions of Arthritic Rats. J. Drug Target 2004, 12, 575–583. DOI: 10.1080/10611860400010655.
   PubMed Web of Science ®Google Scholar
• Gellan Gum. In Thermoreversible Networks: Viscoelastic Properties and Structure of Gels; Springer Berlin Heidelberg: Berlin; Heidelberg, 1997; pp 219–235. DOI: 10.1007/BFb0008712.
   Google Scholar
• Kersten, G.; Hirschberg, H. Antigen Delivery Systems. Expert Rev. Vaccines 2004, 3, 453–462. DOI: 10.1586/14760584.3.4.453.
   PubMedGoogle Scholar
• Chao, Y.; Xu, L.; Liang, C.; Feng, L.; Xu, J.; Dong, Z.; Tian, L.; Yi, X.; Yang, K.; Liu, Z. Combined Local Immunostimulatory Radioisotope Therapy and Systemic Immune Checkpoint Blockade Imparts Potent Antitumour Responses. Nat. Biomed. Eng. 2018, 2, 611–621. DOI: 10.1038/s41551-018-0262-6.
   PubMed Web of Science ®Google Scholar
• Shu, G.; Zhu, W.; Jiang, Y.; Li, X.; Pan, J.; Zhang, X.; Zhang, X.; Sun, S.-K. Persistent Luminescence Immune Hydrogel for Photodynamic-Immunotherapy of Tumors In Vivo. Adv. Funct. Mater. 2021, 31, 2104472. DOI: 10.1002/adfm.202104472.
   Web of Science ®Google Scholar
• Castro, F.; Pinto, M. L.; Pereira, C. L.; Serre, K.; Barbosa, M. A.; Vermaelen, K.; Gärtner, F.; Gonçalves, R. M.; De Wever, O.; Oliveira, M. J. Chitosan/γ-PGA Nanoparticles-Based Immunotherapy as Adjuvant to Radiotherapy in Breast Cancer. Biomaterials 2020, 257, 120218. DOI: 10.1016/j.biomaterials.2020.120218.
   PubMed Web of Science ®Google Scholar
• Verbeke, C. S.; Gordo, S.; Schubert, D. A.; Lewin, S. A.; Desai, R. M.; Dobbins, J.; Wucherpfennig, K. W.; Mooney, D. J. Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation. Adv. Healthc. Mater. 2017, 6, 1600773. DOI: 10.1002/adhm.201600773.
   Web of Science ®Google Scholar
• Verbeke, C. S.; Mooney, D. J. Injectable, Pore-Forming Hydrogels for In Vivo Enrichment of Immature Dendritic Cells. Adv. Healthc. Mater. 2015, 4, 2677–2687. DOI: 10.1002/adhm.201500618.
   PubMed Web of Science ®Google Scholar
• Liu, Y.; Han, Y.-Y.; Lu, S.; Wu, Y.; Li, J.; Sun, X.; Yan, J. Injectable Hydrogel Platform with Biodegradable Dawson-Type Polyoxometalate and R848 for Combinational Photothermal-Immunotherapy of Cancer. Biomater. Sci. 2022, 10, 1257–1266. DOI: 10.1039/D1BM01835C.
   PubMed Web of Science ®Google Scholar
• Polack, F. P.; Thomas, S. J.; Kitchin, N.; Absalon, J.; Gurtman, A.; Lockhart, S.; Perez, J. L.; Pérez Marc, G.; Moreira, E. D.; Zerbini, C.; et al. Safety and Efficacy of the BNT162b2 MRNA Covid-19 Vaccine. N. Engl. J. Med. 2020, 383, 2603–2615. DOI: 10.1056/NEJMoa2034577.
   PubMed Web of Science ®Google Scholar
• Baden, L. R.; El Sahly, H. M.; Essink, B.; Kotloff, K.; Frey, S.; Novak, R.; Diemert, D.; Spector, S. A.; Rouphael, N.; Creech, C. B.; et al. Efficacy and Safety of the MRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021, 384, 403–416. DOI: 10.1056/NEJMoa2035389.
   PubMed Web of Science ®Google Scholar
• Corbett, K. S.; Edwards, D. K.; Leist, S. R.; Abiona, O. M.; Boyoglu-Barnum, S.; Gillespie, R. A.; Himansu, S.; Schäfer, A.; Ziwawo, C. T.; DiPiazza, A. T.; et al. SARS-CoV-2 MRNA Vaccine Design Enabled by Prototype Pathogen Preparedness. Nature 2020, 586, 567–571. DOI: 10.1038/s41586-020-2622-0.
   PubMed Web of Science ®Google Scholar
• Vogel, A. B.; Kanevsky, I.; Che, Y.; Swanson, K. A.; Muik, A.; Vormehr, M.; Kranz, L. M.; Walzer, K. C.; Hein, S.; Güler, A.; et al. BNT162b Vaccines Protect Rhesus Macaques from SARS-CoV-2. Nature 2021, 592, 283–289. DOI: 10.1038/s41586-021-03275-y.
   PubMed Web of Science ®Google Scholar
• Yan, J.; Chen, R.; Zhang, H.; Bryers, J. D. Injectable Biodegradable Chitosan-Alginate 3D Porous Gel Scaffold for MRNA Vaccine Delivery. Macromol. Biosci. 2019, 19, e1800242. DOI: 10.1002/mabi.201800242.
   PubMed Web of Science ®Google Scholar
• Duong, H. T. T.; Thambi, T.; Yin, Y.; Kim, S. H.; Nguyen, T. L.; Phan, V. H. G.; Kim, J.; Jeong, J. H.; Lee, D. S. Degradation-Regulated Architecture of Injectable Smart Hydrogels Enhances Humoral Immune Response and Potentiates Antitumor Activity in Human Lung Carcinoma. Biomaterials 2020, 230, 119599. DOI: 10.1016/j.biomaterials.2019.119599.
   PubMed Web of Science ®Google Scholar
• Lin, H.; Li, Q.; Wang, O.; Rauch, J.; Harm, B.; Viljoen, H. J.; Zhang, C.; Van Wyk, E.; Zhang, C.; Lei, Y. Automated Expansion of Primary Human T Cells in Scalable and Cell-Friendly Hydrogel Microtubes for Adoptive Immunotherapy. Adv. Healthc. Mater. 2018, 7, e1701297. DOI: 10.1002/adhm.201701297.
   PubMed Web of Science ®Google Scholar
• Stephan, S. B.; Taber, A. M.; Jileaeva, I.; Pegues, E. P.; Sentman, C. L.; Stephan, M. T. Biopolymer Implants Enhance the Efficacy of Adoptive T-Cell Therapy. Nat. Biotechnol. 2015, 33, 97–101. DOI: 10.1038/nbt.3104.
   PubMed Web of Science ®Google Scholar
• Ahn, Y. H.; Ren, L.; Kim, S. M.; Seo, S.-H.; Jung, C.-R.; Kim, D. S.; Noh, J.-Y.; Lee, S. Y.; Lee, H.; Cho, M. Y.; et al. A Three-Dimensional Hyaluronic Acid-Based Niche Enhances the Therapeutic Efficacy of Human Natural Killer Cell-Based Cancer Immunotherapy. Biomaterials 2020, 247, 119960. DOI: 10.1016/j.biomaterials.2020.119960.
   PubMed Web of Science ®Google Scholar
• Smith, T. T.; Moffett, H. F.; Stephan, S. B.; Opel, C. F.; Dumigan, A. G.; Jiang, X.; Pillarisetty, V. G.; Pillai, S. P. S.; Wittrup, K. D.; Stephan, M. T. Biopolymers Codelivering Engineered T Cells and STING Agonists Can Eliminate Heterogeneous Tumors. J. Clin. Invest. 2017, 127, 2176–2191. DOI: 10.1172/JCI87624.
   PubMed Web of Science ®Google Scholar
• Sinha, A.; Choi, Y.; Nguyen, M. H.; Nguyen, T. L.; Choi, S. W.; Kim, J. A 3D Macroporous Alginate Graphene Scaffold with an Extremely Slow Release of a Loaded Cargo for In Situ Long-Term Activation of Dendritic Cells. Adv. Healthc. Mater. 2019, 8, e1800571. DOI: 10.1002/adhm.201800571.
   PubMed Web of Science ®Google Scholar
• Schwenter, F.; Zarei, S.; Luy, P.; Padrun, V.; Bouche, N.; Lee, J. S.; Mulligan, R. C.; Morel, P.; Mach, N. Cell Encapsulation Technology as a Novel Strategy for Human Anti-Tumor Immunotherapy. Cancer Gene Ther. 2011, 18, 553–562. DOI: 10.1038/cgt.2011.22.
   PubMed Web of Science ®Google Scholar
• Moran, D. M.; Koniaris, L. G.; Jablonski, E. M.; Cahill, P. A.; Halberstadt, C. R.; McKillop, I. H. Microencapsulation of Engineered Cells to Deliver Sustained High Circulating Levels of Interleukin-6 to Study Hepatocellular Carcinoma Progression. Cell Transplant. 2006, 15, 785–798. DOI: 10.3727/000000006783981477.
   PubMed Web of Science ®Google Scholar
• Cirone, P.; Bourgeois, J. M.; Shen, F.; Chang, P. L. Combined Immunotherapy and Antiangiogenic Therapy of Cancer with Microencapsulated Cells. Hum. Gene Ther. 2004, 15, 945–959. DOI: 10.1089/hum.2004.15.945.
   PubMed Web of Science ®Google Scholar
• Huang, X. Q. Depot Cytokines and Chemokines for Antitumor Therapy in a Mouse Model. 2005.
   Google Scholar
• Atik, A. F.; Suryadevara, C. M.; Schweller, R. M.; West, J. L.; Healy, P.; Herndon Ii, J. E.; Congdon, K. L.; Sanchez-Perez, L.; McLendon, R. E.; Archer, G. E.; et al. Hyaluronic Acid Based Low Viscosity Hydrogel as a Novel Carrier for Convection Enhanced Delivery of CAR T Cells. J. Clin. Neurosci. 2018, 56, 163–168. DOI: 10.1016/j.jocn.2018.06.005.
   PubMed Web of Science ®Google Scholar
• Dautzenberg, H.; Schuldt, U.; Grasnick, G.; Karle, P.; Müller, P.; Löhr, M.; Pelegrin, M.; Piechaczyk, M.; Rombs, K. V.; Günzburg, W. H.; et al. Development of Cellulose Sulfate‐Based Polyelectrolyte Complex Microcapsules for Medical Applications. Ann. N. Y. Acad. Sci. 1999, 875, 46–63. DOI: 10.1111/j.1749-6632.1999.tb08493.x.
   PubMed Web of Science ®Google Scholar
• Abastado, J. S.; Gunzburg, W. H.; Brandtner, E. M. The Diversity of Uses for Cellulose Sulphate Encapsulation. Bioencapsulation Living Cells Divers. Med. Appl. Bentham Sci. 2013, 1, 70–92.
   Google Scholar
• Salmons, B.; Gunzburg, W. H. Release Characteristics of Cellulose Sulphate Capsules and Production of Cytokines from Encapsulated Cells. Int. J. Pharm. 2018, 548, 15–22. DOI: 10.1016/j.ijpharm.2018.06.040.
   PubMedGoogle Scholar
• Yung, C. W.; Bentley, W. E.; Barbari, T. A. Diffusion of Interleukin-2 from Cells Overlaid with Cytocompatible Enzyme-Crosslinked Gelatin Hydrogels. J. Biomed. Mater. Res. A 2010, 95, 25–32. DOI: 10.1002/jbm.a.32740.
   PubMedGoogle Scholar
• Engelke, L.; Winter, G.; Hook, S.; Engert, J. Recent Insights into Cutaneous Immunization: How to Vaccinate via the Skin. Vaccine 2015, 33, 4663–4674. DOI: 10.1016/j.vaccine.2015.05.012.
   PubMed Web of Science ®Google Scholar
• Chen, M.-C.; Lai, K.-Y.; Ling, M.-H.; Lin, C.-W. Enhancing Immunogenicity of Antigens through Sustained Intradermal Delivery Using Chitosan Microneedles with a Patch-Dissolvable Design. Acta Biomater. 2018, 65, 66–75. DOI: 10.1016/J.ACTBIO.2017.11.004.
   PubMed Web of Science ®Google Scholar
• Leone, M.; Priester, M. I.; Romeijn, S.; Nejadnik, M. R.; Mönkäre, J.; O'Mahony, C.; Jiskoot, W.; Kersten, G.; Bouwstra, J. A. Hyaluronan-Based Dissolving Microneedles with High Antigen Content for Intradermal Vaccination: Formulation, Physicochemical Characterization and Immunogenicity Assessment. Eur. J. Pharm. Biopharm. 2019, 134, 49–59. DOI: 10.1016/j.ejpb.2018.11.013.
   PubMed Web of Science ®Google Scholar
• Chiu, Y.-H.; Chen, M.-C.; Wan, S.-W. Sodium Hyaluronate/Chitosan Composite Microneedles as a Single-Dose Intradermal Immunization System. Biomacromolecules 2018, 19, 2278–2285. DOI: 10.1021/acs.biomac.8b00441.
   PubMed Web of Science ®Google Scholar
• Ye, Y.; Wang, C.; Zhang, X.; Hu, Q.; Zhang, Y.; Liu, Q.; Wen, D.; Milligan, J.; Bellotti, A.; Huang, L.; et al. A Melanin-Mediated Cancer Immunotherapy Patch. Sci. Immunol. 2017, 2. DOI: 10.1126/sciimmunol.aan5692.
   Web of Science ®Google Scholar
• Kim, H.; Seong, K.-Y.; Lee, J. H.; Park, W.; Yang, S. Y.; Hahn, S. K. Biodegradable Microneedle Patch Delivering Antigenic Peptide-Hyaluronate Conjugate for Cancer Immunotherapy. ACS Biomater. Sci. Eng. 2019, 5, 5150–5158. DOI: 10.1021/acsbiomaterials.9b00961.
   PubMed Web of Science ®Google Scholar
• Puigmal, N.; Dosta, P.; Solhjou, Z.; Yatim, K.; Ramírez, C.; Choi, J. Y.; Alhaddad, J. B.; Cosme, A. P.; Azzi, J.; Artzi, N. Microneedle-Based Local Delivery of CCL22 and IL-2 Enriches Treg Homing to the Skin Allograft and Enables Temporal Monitoring of Immunotherapy Efficacy. Adv. Funct. Mater. 2021, 31, 2100128. DOI: 10.1002/adfm.202100128.
   Web of Science ®Google Scholar
• Wang, C.; Ye, Y.; Hochu, G. M.; Sadeghifar, H.; Gu, Z. Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody. Nano Lett. 2016, 16, 2334–2340. DOI: 10.1021/acs.nanolett.5b05030.
   PubMed Web of Science ®Google Scholar
• Yang, P.; Lu, C.; Qin, W.; Chen, M.; Quan, G.; Liu, H.; Wang, L.; Bai, X.; Pan, X.; Wu, C. Construction of a Core-Shell Microneedle System to Achieve Targeted Co-delivery of Checkpoint Inhibitors for Melanoma Immunotherapy. Acta Biomater. 2020, 104, 147–157. DOI: 10.1016/j.actbio.2019.12.037.
   PubMed Web of Science ®Google Scholar
• Joo, S.-H.; Kim, J.; Hong, J.; Fakhraei Lahiji, S.; Kim, Y.-H. Dissolvable Self-Locking Microneedle Patches Integrated with Immunomodulators for Cancer Immunotherapy. Adv. Mater. 2023, 35, 2209966. DOI: 10.1002/adma.202209966.
   Web of Science ®Google Scholar
• Tsai, W.; Tsai, H.; Wong, Y.; Hong, J.; Chang, S.; Lee, M. Preparation and Characterization of Gellan Gum/Glucosamine/Clioquinol Film as Oral Cancer Treatment Patch. Mater. Sci. Eng. C Mater. Biol. Appl. 2018, 82, 317–322. DOI: 10.1016/j.msec.2017.05.040.
   PubMed Web of Science ®Google Scholar
• Engelke, L.; Winter, G.; Engert, J. Application of Water-Soluble Polyvinyl Alcohol-Based Film Patches on Laser Microporated Skin Facilitates Intradermal Macromolecule and Nanoparticle Delivery. Eur. J. Pharm. Biopharm. 2018, 128, 119–130. DOI: 10.1016/j.ejpb.2018.04.008.
   PubMed Web of Science ®Google Scholar
• Abioye, A. O.; Issah, S.; Kola-Mustapha, A. T. Ex Vivo Skin Permeation and Retention Studies on Chitosan–Ibuprofen–Gellan Ternary Nanogel Prepared by In Situ Ionic Gelation Technique—A Tool for Controlled Transdermal Delivery of Ibuprofen. Int. J. Pharm. 2015, 490, 112–130. DOI: 10.1016/j.ijpharm.2015.05.030.
   PubMed Web of Science ®Google Scholar
• Bigucci, F.; Abruzzo, A.; Saladini, B.; Gallucci, M. C.; Cerchiara, T.; Luppi, B. Development and Characterization of Chitosan/Hyaluronan Film for Transdermal Delivery of Thiocolchicoside. Carbohydr. Polym. 2015, 130, 32–40. DOI: 10.1016/j.carbpol.2015.04.067.
   PubMed Web of Science ®Google Scholar
• Morad, H.; Jahanshahi, M.; Akbari, J.; Saeedi, M.; Gill, P.; Enayatifard, R. Novel Topical and Transdermal Delivery of Colchicine with Chitosan Based Biocomposite Nanofiberous System; Formulation, Optimization, Characterization, Ex Vivo Skin Deposition/Permeation, and Anti-Melanoma Evaluation. Mater. Chem. Phys. 2021, 263, 124381. DOI: 10.1016/j.matchemphys.2021.124381.
   Web of Science ®Google Scholar
• Li, Y.; Li, X.; Doughty, A.; West, C.; Wang, L.; Zhou, F.; Nordquist, R. E.; Chen, W. R. Phototherapy Using Immunologically Modified Carbon Nanotubes to Potentiate Checkpoint Blockade for Metastatic Breast Cancer. Nanomedicine 2019, 18, 44–53. DOI: 10.1016/j.nano.2019.02.009.
   PubMed Web of Science ®Google Scholar
• Saha, L. C.; Nag, O. K.; Doughty, A.; Liu, H.; Chen, W. R. An Immunologically Modified Nanosystem Based on Noncovalent Binding Between Single-Walled Carbon Nanotubes and Glycated Chitosan. Technol. Cancer Res. Treat. 2018, 17, 1533033818802313. DOI: 10.1177/1533033818802313.
   Web of Science ®Google Scholar
• Lin, L.; He, J.; Li, J.; Xu, Y.; Li, J.; Wu, Y. Chitosan Nanoparticles Strengthen Vγ9Vδ2 T-Cell Cytotoxicity Through Upregulation Of Killing Molecules And Cytoskeleton Polarization. Int. J. Nanomedicine 2019, 14, 9325–9336. DOI: 10.2147/IJN.S212898.
   PubMed Web of Science ®Google Scholar
• Wusiman, A.; Gu, P.; Liu, Z.; Xu, S.; Zhang, Y.; Hu, Y.; Liu, J.; Wang, D.; Huang, X. Cationic Polymer Modified PLGA Nanoparticles Encapsulating Alhagi Honey Polysaccharides as a Vaccine Delivery System for Ovalbumin to Improve Immune Responses. Int. J. Nanomedicine 2019, 14, 3221–3234. DOI: 10.2147/IJN.S203072.
   PubMed Web of Science ®Google Scholar
• Tahamtan, A.; Barati, M.; Tabarraei, A.; Mohebbi, S. R.; Shirian, S.; Gorji, A.; Ghaemi, A. Antitumor Immunity Induced by Genetic Immunization with Chitosan Nanoparticle Formulated Adjuvanted for HPV-16 E7 DNA Vaccine. Iran. J. Immunol. 2018, 15, 269–280. DOI: 10.22034/IJI.2018.39396.
   PubMed Web of Science ®Google Scholar
• Hoemann, C. D.; Fong, D. 3 – Immunological Responses to Chitosan for Biomedical Applications. In Chitosan Based Biomaterials, Jennings, J. A., Bumgardner, J. D. B. T.-C. B. B., Eds.; Woodhead Publishing: United Kingdom, 2017; Vol. 1, pp 45–79. DOI: 10.1016/B978-0-08-100230-8.00003-0.
   Google Scholar
• Zaharoff, D. A.; Hance, K. W.; Rogers, C. J.; Schlom, J.; Greiner, J. W. Intratumoral Immunotherapy of Established Solid Tumors with Chitosan/IL-12. J. Immunother. 2010, 33, 697–705. DOI: 10.1097/CJI.0b013e3181eb826d.
   PubMed Web of Science ®Google Scholar
• Choi, J. J.; Le, Q.-V.; Kim, D.; Kim, Y. B.; Shim, G.; Oh, Y.-K. High Molecular Weight Chitosan-Complexed RNA Nanoadjuvant for Effective Cancer Immunotherapy. Pharmaceutics 2019, 11, 680. DOI: 10.3390/pharmaceutics11120680.
   PubMed Web of Science ®Google Scholar
• Maiyo, F.; Singh, M. Folate-Targeted MRNA Delivery Using Chitosan-Functionalized Selenium Nanoparticles: Potential in Cancer Immunotherapy. Pharmaceuticals 2019, 12 (4),164. DOI: 10.3390/ph12040164.
   Web of Science ®Google Scholar
• Masjedi, A.; Hassannia, H.; Atyabi, F.; Rastegari, A.; Hojjat-Farsangi, M.; Namdar, A.; Soleimanpour, H.; Azizi, G.; Nikkhoo, A.; Ghalamfarsa, G.; et al. Downregulation of A2AR by SiRNA Loaded PEG-Chitosan-Lactate Nanoparticles Restores the T Cell Mediated Anti-Tumor Responses through Blockage of PKA/CREB Signaling Pathway. Int. J. Biol. Macromol. 2019, 133, 436–445. DOI: 10.1016/j.ijbiomac.2019.03.223.
   PubMed Web of Science ®Google Scholar
• Arab, S.; Kheshtchin, N.; Ajami, M.; Ashurpoor, M.; Safvati, A.; Namdar, A.; Mirzaei, R.; Mousavi Niri, N.; Jadidi-Niaragh, F.; Ghahremani, M. H.; et al. Increased Efficacy of a Dendritic Cell-Based Therapeutic Cancer Vaccine with Adenosine Receptor Antagonist and CD73 Inhibitor. Tumour Biol. 2017, 39, 1010428317695021. DOI: 10.1177/1010428317695021.
   Google Scholar
• Dong, Z.; Kang, Y.; Yuan, Q.; Luo, M.; Gu, Z. H(2)O(2)-Responsive Nanoparticle Based on the Supramolecular Self-Assemble of Cyclodextrin. Front. Pharmacol. 2018, 9, 552. DOI: 10.3389/fphar.2018.00552.
   PubMed Web of Science ®Google Scholar
• Lisanti, M. P.; Martinez-Outschoorn, U. E.; Lin, Z.; Pavlides, S.; Whitaker-Menezes, D.; Pestell, R. G.; Howell, A.; Sotgia, F. Hydrogen Peroxide Fuels Aging, Inflammation, Cancer Metabolism and Metastasis: The Seed and Soil Also Needs “Fertilizer”. Cell Cycle 2011, 10, 2440–2449. DOI: 10.4161/cc.10.15.16870.
   PubMed Web of Science ®Google Scholar
• Cai, Z.; Xin, F.; Wei, Z.; Wu, M.; Lin, X.; Du, X.; Chen, G.; Zhang, D.; Zhang, Z.; Liu, X.; et al. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy. Adv. Healthc. Mater. 2020, 9, e1900996. DOI: 10.1002/adhm.201900996.
   PubMed Web of Science ®Google Scholar
• Sun, W.; Du, Y.; Liang, X.; Yu, C.; Fang, J.; Lu, W.; Guo, X.; Tian, J.; Jin, Y.; Zheng, J. Synergistic Triple-Combination Therapy with Hyaluronic Acid-Shelled PPy/CPT Nanoparticles Results in Tumor Regression and Prevents Tumor Recurrence and Metastasis in 4T1 Breast Cancer. Biomaterials 2019, 217, 119264. DOI: 10.1016/j.biomaterials.2019.119264.
   PubMed Web of Science ®Google Scholar
• Bartheldyová, E.; Effenberg, R.; Mašek, J.; Procházka, L.; Knötigová, P. T.; Kulich, P.; Hubatka, F.; Velínská, K.; Zelníčková, J.; Zouharová, D.; et al. Hyaluronic Acid Surface Modified Liposomes Prepared via Orthogonal Aminoxy Coupling: Synthesis of Nontoxic Aminoxylipids Based on Symmetrically α-Branched Fatty Acids, Preparation of Liposomes by Microfluidic Mixing, and Targeting to Cancer Cells Expressi. Bioconjug. Chem. 2018, 29, 2343–2356. DOI: 10.1021/acs.bioconjchem.8b00311.
   PubMed Web of Science ®Google Scholar
• Lee, H.; Park, H.; Yu, H. S.; Na, K.; Oh, K. T.; Lee, E. S. Dendritic Cell-Targeted PH-Responsive Extracellular Vesicles for Anticancer Vaccination. Pharmaceutics 2019, 11, 54. DOI: 10.3390/pharmaceutics11020054.
   PubMed Web of Science ®Google Scholar
• He, M.; Huang, L.; Hou, X.; Zhong, C.; Bachir, Z. A.; Lan, M.; Chen, R.; Gao, F. Efficient Ovalbumin Delivery Using a Novel Multifunctional Micellar Platform for Targeted Melanoma Immunotherapy. Int. J. Pharm. 2019, 560, 1–10. DOI: 10.1016/j.ijpharm.2019.01.027.
   PubMedGoogle Scholar
• Li, C.-X.; Zhang, Y.; Dong, X.; Zhang, L.; Liu, M.-D.; Li, B.; Zhang, M.-K.; Feng, J.; Zhang, X.-Z. Artificially Reprogrammed Macrophages as Tumor-Tropic Immunosuppression-Resistant Biologics to Realize Therapeutics Production and Immune Activation. Adv. Mater. 2019, 31, e1807211. DOI: 10.1002/adma.201807211.
   PubMed Web of Science ®Google Scholar
• Thiery, J.; Keefe, D.; Boulant, S.; Boucrot, E.; Walch, M.; Martinvalet, D.; Goping, I. S.; Bleackley, R. C.; Kirchhausen, T.; Lieberman, J. Perforin Pores in the Endosomal Membrane Trigger the Release of Endocytosed Granzyme B into the Cytosol of Target Cells. Nat. Immunol. 2011, 12, 770–777. DOI: 10.1038/ni.2050.
   PubMed Web of Science ®Google Scholar
• Qian, X.; Shi, Z.; Qi, H.; Zhao, M.; Huang, K.; Han, D.; Zhou, J.; Liu, C.; Liu, Y.; Lu, Y.; et al. A Novel Granzyme B Nanoparticle Delivery System Simulates Immune Cell Functions for Suppression of Solid Tumors. Theranostics 2019, 9, 7616–7627. DOI: 10.7150/thno.35900.
   PubMed Web of Science ®Google Scholar
• Li, Q.; Zhang, D.; Zhang, J.; Jiang, Y.; Song, A.; Li, Z.; Luan, Y. A Three-in-One Immunotherapy Nanoweapon via Cascade-Amplifying Cancer-Immunity Cycle against Tumor Metastasis, Relapse, and Postsurgical Regrowth. Nano Lett. 2019, 19, 6647–6657. DOI: 10.1021/acs.nanolett.9b02923.
   PubMed Web of Science ®Google Scholar
• Lu, R.; Groer, C.; Kleindl, P. A.; Moulder, K. R.; Huang, A.; Hunt, J. R.; Cai, S.; Aires, D. J.; Berkland, C.; Forrest, M. L. Formulation and Preclinical Evaluation of a Toll-Like Receptor 7/8 Agonist as an Anti-Tumoral Immunomodulator. J. Control Release 2019, 306, 165–176. DOI: 10.1016/j.jconrel.2019.06.003.
   PubMed Web of Science ®Google Scholar
• Gao, F.; Zhang, C.; Qiu, W.-X.; Dong, X.; Zheng, D.-W.; Wu, W.; Zhang, X.-Z. PD-1 Blockade for Improving the Antitumor Efficiency of Polymer-Doxorubicin Nanoprodrug. Small 2018, 14, e1802403. DOI: 10.1002/smll.201802403.
   PubMed Web of Science ®Google Scholar
• Salazar, A. Method for Preparation of Poly-Iclc and Uses Thereof. WO2005102278A1, July 1, 2003.
   Google Scholar
• Hammerich, L.; Marron, T. U.; Upadhyay, R.; Svensson-Arvelund, J.; Dhainaut, M.; Hussein, S.; Zhan, Y.; Ostrowski, D.; Yellin, M.; Marsh, H.; et al. Systemic Clinical Tumor Regressions and Potentiation of PD1 Blockade with In Situ Vaccination. Nat. Med. 2019, 25, 814–824. DOI: 10.1038/s41591-019-0410-x.
   PubMed Web of Science ®Google Scholar
• Chapman, N. M.; Gottschalk, S.; Chi, H. Preventing Ubiquitination Improves CAR T Cell Therapy via ‘CAR Merry-Go-Around’. Immunity 2020, 53, 243–245. DOI: 10.1016/j.immuni.2020.07.023.
   PubMed Web of Science ®Google Scholar
• Li, W.; Qiu, S.; Chen, J.; Jiang, S.; Chen, W.; Jiang, J.; Wang, F.; Si, W.; Shu, Y.; Wei, P.; et al. Chimeric Antigen Receptor Designed to Prevent Ubiquitination and Downregulation Showed Durable Antitumor Efficacy. Immunity 2020, 53, 456–470.e6. DOI: 10.1016/j.immuni.2020.07.011.
   PubMed Web of Science ®Google Scholar
• Tie, Y.; Tang, F.; Wei, Y.; Wei, X. Immunosuppressive Cells in Cancer: Mechanisms and Potential Therapeutic Targets. J. Hematol. Oncol. 2022, 15, 61. DOI: 10.1186/s13045-022-01282-8.
   PubMed Web of Science ®Google Scholar
• Li, X.; Wang, S.; Mu, W.; Barry, J.; Han, A.; Carpenter, R. L.; Jiang, B.-H.; Peiper, S. C.; Mahoney, M. G.; Aplin, A. E.; et al. Reactive Oxygen Species Reprogram Macrophages to Suppress Antitumor Immune Response through the Exosomal MiR-155-5p/PD-L1 Pathway. J. Exp. Clin. Cancer Res. 2022, 41, 41. DOI: 10.1186/s13046-022-02244-1.
   PubMed Web of Science ®Google Scholar
• Muth, S.; Klaric, A.; Radsak, M.; Schild, H.; Probst, H. C. CD27 Expression on Treg Cells Limits Immune Responses against Tumors. J. Mol. Med. 2022, 100, 439–449. DOI: 10.1007/s00109-021-02116-9.
   PubMed Web of Science ®Google Scholar
• Assi, H. H.; Wong, C.; Tipton, K. A.; Mei, L.; Wong, K.; Razo, J.; Chan, C.; Howng, B.; Sagert, J.; Krimm, M.; et al. Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 Agents. Cancer Immunol. Res. 2021, 9, 1451–1464. DOI: 10.1158/2326-6066.CIR-21-0031.
   PubMed Web of Science ®Google Scholar
• Boustany, L. M.; LaPorte, S. L.; Wong, L.; White, C.; Vinod, V.; Shen, J.; Yu, W.; Koditek, D.; Winter, M. B.; Moore, S. J.; et al. A Probody T Cell-Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity. Cancer Res. 2022, 82, 4288–4298. DOI: 10.1158/0008-5472.CAN-21-2483.
   PubMedGoogle Scholar
• Naing, A.; Thistlethwaite, F.; De Vries, E. G. E.; Eskens, F. A. L. M.; Uboha, N.; Ott, P. A.; LoRusso, P.; Garcia-Corbacho, J.; Boni, V.; Bendell, J.; et al. CX-072 (Pacmilimab), a Probody (®) PD-L1 Inhibitor, in Advanced or Recurrent Solid Tumors (PROCLAIM-CX-072): An Open-Label Dose-Finding and First-in-Human Study. J. Immunother. Cancer 2021, 9, e002447. DOI: 10.1136/jitc-2021-002447.
   PubMed Web of Science ®Google Scholar
• Han, X.; Bryson, P. D.; Zhao, Y.; Cinay, G. E.; Li, S.; Guo, Y.; Siriwon, N.; Wang, P. Masked Chimeric Antigen Receptor for Tumor-Specific Activation. Mol. Ther. 2017, 25, 274–284. DOI: 10.1016/j.ymthe.2016.10.011.
   PubMed Web of Science ®Google Scholar
• Juillerat, A.; Marechal, A.; Filhol, J. M.; Valogne, Y.; Valton, J.; Duclert, A.; Duchateau, P.; Poirot, L. An Oxygen Sensitive Self-Decision Making Engineered CAR T-Cell. Sci. Rep. 2017, 7, 39833. DOI: 10.1038/srep39833.
   PubMed Web of Science ®Google Scholar
• Alkhader, E.; Billa, N.; Roberts, C. J. Mucoadhesive Chitosan-Pectinate Nanoparticles for the Delivery of Curcumin to the Colon. AAPS PharmSciTech 2017, 18, 1009–1018. DOI: 10.1208/s12249-016-0623-y.
   PubMed Web of Science ®Google Scholar
• Saeed, R. M.; Dmour, I.; Taha, M. O. Stable Chitosan-Based Nanoparticles Using Polyphosphoric Acid or Hexametaphosphate for Tandem Ionotropic/Covalent Crosslinking and Subsequent Investigation as Novel Vehicles for Drug Delivery. Front. Bioeng. Biotechnol. 2020, 8, 4. DOI: 10.3389/fbioe.2020.00004.
   PubMed Web of Science ®Google Scholar
• Espinosa-Cano, E.; Huerta-Madronal, M.; Camara-Sanchez, P.; Seras-Franzoso, J.; Schwartz, S. Jr.; Abasolo, I.; San Román, J.; Aguilar, M. R. Hyaluronic Acid (HA)-Coated Naproxen-Nanoparticles Selectively Target Breast Cancer Stem Cells through COX-Independent Pathways. Mater. Sci. Eng. C Mater. Biol. Appl. 2021, 124, 112024. DOI: 10.1016/j.msec.2021.112024.
   PubMed Web of Science ®Google Scholar
• Festas, A. J.; Ramos, A.; Davim, J. P. Medical Devices Biomaterials – A Review. Proc. Inst. Mech. Eng. Part L. J. Mater. Des. Appl. 2020, 234, 218–228. DOI: 10.1177/1464420719882458.
   Google Scholar
• Zhu, L.; Ge, F.; Yang, L.; Li, W.; Wei, S.; Tao, Y.; Du, G. Alginate Particles with Ovalbumin (OVA) Peptide Can Serve as a Carrier and Adjuvant for Immune Therapy in B16-OVA Cancer Model. Med. Sci. Monit. Basic Res. 2017, 23, 166–172. DOI: 10.12659/MSMBR.901576.
   PubMedGoogle Scholar
• Kim, S.; Heo, R.; Song, S. H.; Song, K.-H.; Shin, J. M.; Oh, S. J.; Lee, H.-J.; Chung, J. E.; Park, J. H.; Kim, T. W. PD-L1 SiRNA-Hyaluronic Acid Conjugate for Dual-Targeted Cancer Immunotherapy. J. Control Release 2022, 346, 226–239. DOI: 10.1016/j.jconrel.2022.04.023.
   PubMed Web of Science ®Google Scholar
• Dalla Pietà, A.; Carpanese, D.; Grigoletto, A.; Tosi, A.; Dalla Santa, S.; Pedersen, G. K.; Christensen, D.; Meléndez-Alafort, L.; Barbieri, V.; De Benedictis, P.; et al. Hyaluronan Is a Natural and Effective Immunological Adjuvant for Protein-Based Vaccines. Cell Mol. Immunol. 2021, 18, 1197–1210. DOI: 10.1038/s41423-021-00667-y.
   PubMed Web of Science ®Google Scholar
• Lee, S.-J.; Lee, H.-S.; Hwang, Y.-H.; Kim, J.-J.; Kang, K.-Y.; Kim, S. J.; Kim, H. K.; Kim, J. D.; Jeong, D. H.; Paik, M.-J.; et al. Enhanced Anti-Tumor Immunotherapy by Dissolving Microneedle Patch Loaded Ovalbumin. PLoS One 2019, 14, e0220382. DOI: 10.1371/journal.pone.0220382.
   PubMed Web of Science ®Google Scholar
• AbdelAllah, N. H.; Gaber, Y.; AbdelGhani, S.; Rashed, M. E.; Azmy, A. F. Chitosan and Alginate Salt as Biomaterials Are Potential Natural Adjuvants for Killed Cholera Vaccine. J. Biomed. Mater. Res. A 2021, 109, 2462–2470. DOI: 10.1002/jbm.a.37240.
   PubMed Web of Science ®Google Scholar
• Norpi, A. S. M.; Nordin, M. L.; Ahmad, N.; Katas, H.; Fuaad, A. A.-H. A.; Sukri, A.; Marasini, N.; Azmi, F. New Modular Platform Based on Multi-Adjuvanted Amphiphilic Chitosan Nanoparticles for Efficient Lipopeptide Vaccine Delivery against Group A Streptococcus. Asian J. Pharm. Sci. 2022, 17, 435–446. DOI: 10.1016/j.ajps.2022.04.002.
   PubMed Web of Science ®Google Scholar
• Catania, G.; Rodella, G.; Vanvarenberg, K.; Préat, V.; Malfanti, A. Combination of Hyaluronic Acid Conjugates with Immunogenic Cell Death Inducer and CpG for Glioblastoma Local Chemo-Immunotherapy Elicits an Immune Response and Induces Long-Term Survival. Biomaterials 2023, 294, 122006. DOI: 10.1016/j.biomaterials.2023.122006.
   PubMed Web of Science ®Google Scholar
• Cao, F.; Yan, M.; Liu, Y.; Liu, L.; Ma, G. Photothermally Controlled MHC Class I Restricted CD8+ T-Cell Responses Elicited by Hyaluronic Acid Decorated Gold Nanoparticles as a Vaccine for Cancer Immunotherapy. Adv. Healthc. Mater. 2018, 7, 1701439. DOI: 10.1002/adhm.201701439.
   PubMed Web of Science ®Google Scholar
• Wu, C.; Xu, J.; Xie, Z.; Huang, H.; Li, N.; Wei, X.; Li, T.; Yang, H.; Li, S.; Qin, X.; et al. Light-Responsive Hyaluronic Acid Nanomicelles Co-Loaded with an IDO Inhibitor Focus Targeted Photoimmunotherapy against “Immune Cold” Cancer. Biomater. Sci. 2021, 9, 8019–8031. DOI: 10.1039/d1bm01409a.
   PubMed Web of Science ®Google Scholar
• Shan, G.; Meihe, L.; Minchao, K.; Rui, Z.; Xiaopeng, W.; Guangjian, Z.; Jin, Z. Identification and Validation of Osteopontin and Receptor for Hyaluronic Acid-Mediated Motility (RHAMM, CD168) for Potential Immunotherapeutic Significance of in Lung Squamous Cell Carcinoma. Int. Immunopharmacol. 2022, 107, 108715. DOI: 10.1016/j.intimp.2022.108715.
   PubMed Web of Science ®Google Scholar
• Claverie, M.; McReynolds, C.; Petitpas, A.; Thomas, M.; Fernandes, S. C. M. Marine-Derived Polymeric Materials and Biomimetics: An Overview. Polymers 2020, 12, 1002. DOI: 10.3390/polym12051002.
   PubMed Web of Science ®Google Scholar
• Saeed, A. F. U. H.; Su, J.; Ouyang, S. Marine-Derived Drugs: Recent Advances in Cancer Therapy and Immune Signaling. Biomed. Pharmacother. 2021, 134, 111091. DOI: 10.1016/j.biopha.2020.111091.
   PubMed Web of Science ®Google Scholar